These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 17096057)

  • 1. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
    Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
    Wu B; Qiu HZ; Xiao Y; Lin GL; Niu BZ; Zhang FQ; Hu K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):124-7. PubMed ID: 18344077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
    Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
    J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.
    Habr-Gama A; Perez RO; Kiss DR; Rawet V; Scanavini A; Santinho PM; Nadalin W
    Hepatogastroenterology; 2004; 51(60):1703-7. PubMed ID: 15532809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
    Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M
    Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of accelerated preoperative hyperfractionated pelvic irradiation with or without low-dose preoperative prophylactic liver irradiation in patients with locally advanced rectal cancer.
    Suwinski R; Wydmanski J; Pawełczyk I; Starzewski J
    Radiother Oncol; 2006 Jul; 80(1):27-32. PubMed ID: 16730087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma.
    Crane CH; Skibber JM; Feig BW; Vauthey JN; Thames HD; Curley SA; Rodriguez-Bigas MA; Wolff RA; Ellis LM; Delclos ME; Lin EH; Janjan NA
    Cancer; 2003 Jan; 97(2):517-24. PubMed ID: 12518377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiation increases the risk of pelvic sepsis after radical excision of rectal cancer.
    Buie WD; MacLean AR; Attard JA; Brasher PM; Chan AK
    Dis Colon Rectum; 2005 Oct; 48(10):1868-74. PubMed ID: 16175323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of neoadjuvant radio-chemotherapy in the treatment of rectal cancer].
    Staudacher C; Di Palo S; Tamburini AM; Vignali A; Orsenigo E
    Ann Ital Chir; 2007; 78(6):493-8. PubMed ID: 18510028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII rectal cancers.
    de Campos-Lobato LF; Stocchi L; da Luz Moreira A; Kalady MF; Geisler D; Dietz D; Lavery IC; Remzi FH; Fazio VW
    Ann Surg Oncol; 2010 Jul; 17(7):1758-66. PubMed ID: 20131015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
    Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I
    ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.
    Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Pudełko M; Kryj M; Oledzki J; Szmeja J; Słuszniak J; Serkies K; Kładny J; Pamucka M; Kukołowicz P
    Radiother Oncol; 2004 Jul; 72(1):15-24. PubMed ID: 15236870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.